| |
| |
|
| Insider
Information: |
Kunz Heidi |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
91,364 |
|
|
Indirect Shares
|
56,654 |
|
|
| Direct
Value |
$8,767,409 |
|
|
|
Indirect Value
|
$8,660,697 |
|
|
| Total
Shares |
148,018 |
|
|
| Total
Value |
$17,428,106 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 21.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agilent Technologies Inc |
A |
Director |
2020-06-04 |
53,509 |
2024-03-15 |
56,654 |
Premium* |
|
|
Financial Engines, Inc. |
FNGN |
Director |
2018-07-19 |
0 |
2013-05-16 |
0 |
Premium* |
|
|
Halyard Health, Inc. |
HYH |
Director |
2021-01-04 |
28,855 |
2014-11-07 |
0 |
Premium* |
|
|
Icosavax, Inc. |
ICVX |
|
2024-02-19 |
0 |
2021-07-30 |
0 |
Premium* |
|
|
Phathom Pharmaceuticals, Inc. |
PHAT |
Director |
2023-05-25 |
9,000 |
2023-05-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| A |
Agilent Technologies Inc |
Director |
• • – |
2020-04-17 |
4 |
A |
$73.01 |
$224,941 |
I/I |
3,081 |
10,392 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2020-06-04 |
4 |
S |
$91.00 |
$945,662 |
I/I |
(10,392) |
0 |
0 |
% |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2020-06-04 |
4/A |
S |
$91.00 |
$945,662 |
I/I |
(10,392) |
130 |
0 |
- |
|
| HYH |
Halyard Health, Inc. |
Director |
– • – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,005 |
28,855 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2021-03-18 |
4 |
A |
$121.59 |
$224,947 |
I/I |
1,850 |
55,768 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Director |
– • – |
2021-07-30 |
4 |
A |
$15.00 |
$131,250 |
D/D |
8,750 |
8,750 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2022-03-17 |
4 |
A |
$136.82 |
$244,224 |
I/I |
1,785 |
57,850 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2022-11-23 |
4 |
S |
$155.84 |
$566,482 |
I/I |
(3,635) |
54,484 |
0 |
% |
|
| A |
Agilent Technologies Inc |
Director |
– • – |
2023-03-16 |
4 |
A |
$136.82 |
$226,848 |
I/I |
1,658 |
56,222 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
See Remarks |
– – – |
2024-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,376) |
0 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
See Remarks |
– – – |
2024-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,917) |
0 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2024-03-05 |
4 |
S |
$144.34 |
$239,316 |
I/I |
(1,658) |
54,976 |
0 |
% |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2024-03-15 |
4 |
A |
$147.48 |
$247,471 |
I/I |
1,678 |
56,654 |
0 |
- |
|
89 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
